• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定的冻干蛋白药物产品的开发。

Development of stable lyophilized protein drug products.

机构信息

Vaccine Formulation Development, MedImmune, 319 Bernardo Ave, Mountain View, CA 94043, USA.

出版信息

Curr Pharm Biotechnol. 2012 Mar;13(3):471-96. doi: 10.2174/138920112799361990.

DOI:10.2174/138920112799361990
PMID:22283723
Abstract

Freeze drying, or lyophilization is widely used for biopharmaceuticals to improve the long term storage stability of labile molecules. This review examines general theory and practice of rational lyophilization of biopharmaceuticals. Formulation development involving the selection of appropriate excipients, their associated physical properties, and mechanism of action in achieving a stable drug product are primary considerations for a successful lyophilization program. There are several parameters considered critical on the basis of their relationship to lyophilization cycle development and protein product stability. This along with the importance of analytical methods to provide insight toward understanding properties of drug product stability and cake structure are discussed. Also, aspects of instability found in lyophilized biopharmaceutical products, their degradation pathways and control are elucidated. Finally, container-closure requirements and drug product handling are described in context of the caveats to avoid compromising drug product quality.

摘要

冷冻干燥,又称冻干,广泛应用于生物制药领域,以提高不稳定分子的长期储存稳定性。本文综述了生物制药合理冻干的一般理论和实践。制剂开发涉及选择合适的赋形剂,及其在实现稳定药物产品方面的相关物理性质和作用机制,是成功冻干方案的主要考虑因素。有几个参数被认为是关键的,因为它们与冻干周期开发和蛋白质产品稳定性有关。本文还讨论了分析方法的重要性,以提供对理解药物产品稳定性和饼状物结构特性的洞察力。此外,还阐述了冻干生物制药产品中发现的不稳定性、其降解途径和控制方面的问题。最后,描述了容器-密封要求和药物产品处理,以避免损害药物产品质量的注意事项。

相似文献

1
Development of stable lyophilized protein drug products.稳定的冻干蛋白药物产品的开发。
Curr Pharm Biotechnol. 2012 Mar;13(3):471-96. doi: 10.2174/138920112799361990.
2
Effect of temperature ramp rate during the primary drying process on the properties of amorphous-based lyophilized cake, Part 2: Successful lyophilization by adopting a fast ramp rate during primary drying in protein formulations.主干燥过程中升温速率对基于无定形的冷冻干燥饼 properties 的影响,第 2 部分:在蛋白质配方的主干燥中采用快速升温速率实现成功冷冻干燥。
Eur J Pharm Biopharm. 2018 Sep;130:83-95. doi: 10.1016/j.ejpb.2018.06.010. Epub 2018 Jun 18.
3
Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.近年来药物制剂中稳定肽和蛋白质的趋势-辅料选择中的考虑因素。
Expert Opin Drug Deliv. 2009 Nov;6(11):1219-30. doi: 10.1517/17425240903199143.
4
Lyophilization of Small-Molecule Injectables: an Industry Perspective on Formulation Development, Process Optimization, Scale-Up Challenges, and Drug Product Quality Attributes.小分子注射剂的冷冻干燥:从行业角度看制剂开发、工艺优化、放大挑战以及药物产品质量属性。
AAPS PharmSciTech. 2020 Sep 3;21(7):252. doi: 10.1208/s12249-020-01787-w.
5
Instability of therapeutic proteins - An overview of stresses, stabilization mechanisms and analytical techniques involved in lyophilized proteins.治疗性蛋白质的不稳定性-冻干蛋白质中涉及的应激、稳定机制和分析技术概述。
Int J Biol Macromol. 2021 Jan 15;167:309-325. doi: 10.1016/j.ijbiomac.2020.11.188. Epub 2020 Dec 1.
6
Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.精氨酸作为无蛋白冷冻干燥赋形剂:综述。
J Pharm Sci. 2018 Apr;107(4):960-967. doi: 10.1016/j.xphs.2017.11.015. Epub 2017 Nov 26.
7
Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.基于L-精氨酸/蔗糖的蛋白质制剂的冷冻干燥,第2部分:基于L-精氨酸氯化物的蛋白质制剂系统的配方设计和冷冻干燥工艺条件的优化
J Pharm Sci. 2015 Dec;104(12):4241-4256. doi: 10.1002/jps.24658. Epub 2015 Sep 30.
8
Mannitol-sucrose mixtures--versatile formulations for protein lyophilization.甘露醇 - 蔗糖混合物——用于蛋白质冻干的通用配方。
J Pharm Sci. 2002 Apr;91(4):914-22. doi: 10.1002/jps.10094.
9
Freeze-drying: A flourishing strategy to fabricate stable pharmaceutical and biological products.冷冻干燥:一种制造稳定药物和生物制品的热门策略。
Int J Pharm. 2022 Nov 25;628:122233. doi: 10.1016/j.ijpharm.2022.122233. Epub 2022 Sep 30.
10
Lyophilized Drug Product Cake Appearance: What Is Acceptable?冻干药品的块状外观:什么是可接受的?
J Pharm Sci. 2017 Jul;106(7):1706-1721. doi: 10.1016/j.xphs.2017.03.014. Epub 2017 Mar 22.

引用本文的文献

1
Automated Tomographic Assessment of Structural Defects of Freeze-Dried Pharmaceuticals.自动化断层扫描评估冻干药品的结构缺陷。
AAPS PharmSciTech. 2024 Jun 25;25(6):143. doi: 10.1208/s12249-024-02833-7.
2
Lyophilization of Nanoparticles, Does It Really Work? Overview of the Current Status and Challenges.纳米颗粒的冷冻干燥,真的可行吗?现状与挑战概述。
Int J Mol Sci. 2023 Sep 13;24(18):14041. doi: 10.3390/ijms241814041.
3
Procedure providing SI-traceable results for the calibration of protein standards by sulfur determination and its application on tau.
通过硫测定对蛋白质标准品进行 SI 可溯源校准的程序及其在 tau 上的应用。
Anal Bioanal Chem. 2022 Jun;414(15):4441-4455. doi: 10.1007/s00216-022-03974-z. Epub 2022 Mar 22.
4
Chitosan-dipotassium orthophosphate lyophilizate: a novel thermogel carrier system of allogeneic platelet lysate growth factors.壳聚糖-焦磷酸二氢钾冻干物:一种新型的同种异体血小板裂解液生长因子的温敏凝胶载体系统。
Drug Deliv. 2022 Dec;29(1):413-426. doi: 10.1080/10717544.2022.2030429.
5
Lyophilization of Nanocapsules: Instability Sources, Formulation and Process Parameters.纳米胶囊的冻干:不稳定性来源、配方及工艺参数
Pharmaceutics. 2021 Jul 21;13(8):1112. doi: 10.3390/pharmaceutics13081112.
6
Evaluation of the Stability of Bacteriophages in Different Solutions Suitable for the Production of Magistral Preparations in Belgium.评价不同溶液中适合在比利时生产药剂师制剂的噬菌体的稳定性。
Viruses. 2021 May 8;13(5):865. doi: 10.3390/v13050865.
7
A novel method for the storage and transport of biological samples of therapeutic proteins prior to the detection of analytes using ELISA.用于在使用 ELISA 检测分析物之前储存和运输治疗性蛋白质生物样品的新方法。
Sci Rep. 2021 Apr 22;11(1):8763. doi: 10.1038/s41598-021-88180-0.
8
Formulation strategies in immunotherapeutic pharmaceutical products.免疫治疗药物产品的制剂策略。
World J Clin Oncol. 2020 May 24;11(5):275-282. doi: 10.5306/wjco.v11.i5.275.
9
Development of a Lyophilized Formulation of Pegaspargase and Comparability Versus Liquid Pegaspargase.聚乙二醇化门冬酰胺酶冻干粉制剂的研制及其与液体聚乙二醇化门冬酰胺酶的可比性。
Adv Ther. 2019 Aug;36(8):2106-2121. doi: 10.1007/s12325-019-00988-5. Epub 2019 May 28.
10
Physical-chemical and biological characterization of different preparations of equine chorionic gonadotropin.马绒毛膜促性腺激素不同制剂的物理化学和生物学特性
J Vet Sci. 2016 Dec 30;17(4):459-465. doi: 10.4142/jvs.2016.17.4.459.